苑东生物：2025年净利润2.83亿元，同比增长18.89%

Core Viewpoint - Yuan Dong Bio reported a slight decrease in total operating revenue for the fiscal year 2025, while achieving a significant increase in net profit, indicating effective management strategies in response to market challenges [1] Financial Performance - Total operating revenue for 2025 reached 1.331 billion yuan, a year-on-year decrease of 1.36% [1] - Net profit for the same period was 283 million yuan, reflecting a year-on-year growth of 18.89% [1] Impact of Market Conditions - The decline in operating revenue was influenced by the implementation of the tenth batch of national centralized procurement standards [1] - The company adopted multiple strategies, including optimizing revenue structure, enhancing cost control, and improving operational efficiency to mitigate the adverse effects of the procurement policy [1] Strategic Initiatives - Yuan Dong Bio successfully increased revenue from technical services and transfers while reducing costs and expenses [1] - These initiatives contributed to a robust growth in profit despite the challenges posed by the procurement policy [1]